Failed studies, alternate designs [BE/BA News]

posted by Helmut Homepage – Vienna, Austria, 2013-12-26 15:10 (3447 d 13:07 ago) – Posting: # 12112
Views: 6,504

Hi kvgreddy06,

THX for reminding us!

❝ […] is going to be comes in effect from 02nd January 2014.

Where do you get this information from? It’s a draft and 20 comments have been submitted so far (although none are posted at yet).

Understandably the FDA wants to decrease its workload refusing failed and alternate designs without previous correspondence*.

line 640: FDA will refuse to receive an ANDA if only a failed study is submitted.
644–647: Submitting a non-recommended in vivo study without adequate justification will result in FDA refusing to receive an ANDA. We encourage applicants to consult the BE recommendations webpage for product-specific study information or to contact the Division of Bioequivalence via Control Correspondence for further guidance if needed.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
 Admin contact
22,616 posts in 4,740 threads, 1,613 registered users;
21 visitors (0 registered, 21 guests [including 7 identified bots]).
Forum time: 05:18 CEST (Europe/Vienna)

Mediocrity is a fungus of the mind.    Reif Larsen

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz